Legend Biotech Corp Capital Reinvestment Ratio
Legend Biotech Corp capital reinvestment ratio. Legend Biotech Corp (LEGN) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow ($28.80 Million) in capital expenditures ($5.00 Million). See Legend Biotech Corp free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Legend Biotech Corp (2018–2018)
Capital reinvestment ratio of Legend Biotech Corp from 2018 to 2018. This chart tracks Legend Biotech Corp's Capital Reinvestment Ratio across 1 annual periods. See financial flexibility index of Legend Biotech Corp to measure the company's free cash flow as a share of total liabilities.
Legend Biotech Corp Capital Reinvestment Ratio by Year (2018–2018)
Legend Biotech Corp capital reinvestment ratio by year from 2018 to 2018. For the full cash flow conversion analysis, see cash efficiency ratio of Legend Biotech Corp.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.07x | $307.68 Million | $21.02 Million | — |